Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: Toward a universal method for the facile quantitation of virus and vector potency

Vaccine

Volumn 23, Issue 36, 2005, Pages 4500-4508

  Wang, Fubao ^a   Puddy, Alan C ^a   Mathis, Bill C ^a   Montalvo, Allison G ^a   Louis, Anthonise A ^a   McMackin, Jennifer L ^a   Xu, Jenny ^a   Zhang, Yuhua ^a   Tan, Charles Y ^a   Schofield, Timothy L ^a   Wolf, Jayanthi J ^a   Lewis, John A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adenovirus; Potency; QPA

Indexed keywords

ADENOVIRUS VECTOR; MEASLES VACCINE; MUMPS VACCINE; VIRUS VACCINE; VIRUS VECTOR;

ACCURACY; ANIMAL CELL; ARTICLE; AUTOMATION; CONTROLLED STUDY; DNA VIRUS; DRUG POTENCY; INOCULATION; MEASLES; MEASLES VIRUS; MUMPS; MUMPS VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA VIRUS; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS TITRATION;

ADENOVIRIDAE; CELL LINE; DNA, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; MEASLES VIRUS; MUMPS VIRUS; POLYMERASE CHAIN REACTION; VACCINES, SYNTHETIC;

EID: 22044436145     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.023     Document Type: Article

References (22)

1. W.P. Rowe, R.J. Huebner, L.K. Gilmore, R.H. Parrott, and T.G. Ward Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture Proc Soc Exp Biol Med 84 3 1953 570 573
2. M.R. Hilleman, and J.H. Werner Recovery of new agent from patients with acute respiratory illness Proc Soc Exp Biol Med 85 1 1954 183 188
3. T. Shenk Adenoviridae: the viruses and their replication P.M. Howley Fields virology 1996 Lippincott-Raven Publishers Philadelphia 2111 2148
4. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J Gen Virol 36 1 1977 59 74
5. P. Ng, and F.L. Graham Construction of first-generation adenoviral vectors Methods Mol Med 69 2002 389 414
6. M. Lusky, E. Degryse, M. Mehtali, and C. Chartier Adenoviral vector construction II: bacterial systems J.T. Douglas Adenoviral vectors for gene therapy 2002 Elsevier Science
7. Edelstein. Gene therapy clinical trials worldwide 1989-2004 - an overview. J Gene Med 2004;6(6):597-602.
8. N. Mittereder, K.L. March, and B.C. Trapnell Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 70 11 1996 7498 7509
9. C. Nyberg-Hoffman, P. Shabram, W. Li, D. Giroux, and E. Aguilar-Cordova Sensitivity and reproducibility in adenoviral infectious titer determination Nat Med 3 7 1997 808 811
10. V. Gueret, J.A. Negrete-Virgen, A. Lyddiatt, and M. Al-Rubeai Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells Cytotechnology 38 2002 87 97
11. B. Bewig, and W.E. Schmidt Accelerated titering of adenoviruses Biotechniques 28 5 2000 870 873
12. E.M. Atkinson, D.J. Debelak, L.A. Hart, and T.C. Reynolds A high-throughput hybridization method for titer determination of viruses and gene therapy vectors Nucl Acids Res 26 11 1998 2821 2823
13. E.A. Emini Ongoing development and evaluation of a potential HIV-1 vaccine using a replication-defective adenoviral vector Keystone Symposium on HIV-1 Vaccine Development. Banff, Canada 2003
14. J.W. Shiver, and E.A. Emini Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors Annu Rev Med 55 2004 355 372
15. I.V. Kutyavin, I.A. Afonina, and A. Mills 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures Nucl Acids Res 28 2 2000 655 661
16. D.J. Finney Probit analysis third ed. 1971 Cambridge University Press
17. J.A. Schalk, C. van den Elzen, H. Ovelgonne, C. Baas, and P.M. Jongen Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR J Virol Methods 117 2 2004 179 187
18. D. Lansky Strip-plot designs, mixed models and comparisons between linear and nonlinear models for microtiter plate bioassays 2002 Karger London
19. R. Vogels, D. Zuijdgeest, and R. van Rijnsoever Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity J Virol 77 15 2003 8263 8271
20. J.A. Lewis, T.S. Ranheim, and F. Wang Novel use of QPCR technology to assay the potency of live virus vaccines. in Well Characterized Biological Products Fifth Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Products 2001
21. Ranheim TS, Mathis PK, Joelsson DB et al. Development and application of a quantitative RT-QPCR assay for a multivalent rotavirus vaccine (Rotateq). 2004;Manuscript in preparation.
22. S. Schlesinger Alphavirus vectors: development and potential therapeutic applications Exp Opin Biol Ther 1 2 2001 177 191